| 1 |
35598697 | Valsartan and sacubitril combination treatment enhances collagen production in older adult human skin cells. | 2022 May 19 |
1 |
| 2 |
34282597 | Prevalence of Primary Aldosteronism Across the Stages of Hypertension Based on a New Combined Overnight Test. | 2021 Jul |
1 |
| 3 |
34453839 | Comparative beneficial effects of nebivolol and nebivolol/valsartan combination against mitochondrial dysfunction in angiotensin II-induced pathology in H9c2 cardiomyoblasts. | 2021 Oct 7 |
4 |
| 4 |
33489085 | Potential mechanisms of beneficial effect of sacubitril/valsartan on glycemic control. | 2020 |
1 |
| 5 |
30536556 | Uric acid and angiotensin II additively promote inflammation and oxidative stress in human proximal tubule cells by activation of toll-like receptor 4. | 2019 Jul |
1 |
| 6 |
30776409 | Long-term stimulation of angiotensin II induced endothelial senescence and dysfunction. | 2019 May |
5 |
| 7 |
30998981 | Downregulation of AT2R decreases the responsiveness of BKCa channels to angiotensin II in patients with hypertension. | 2019 Jun |
1 |
| 8 |
31803758 | Activation of the Human Angiotensin-(1-12)-Chymase Pathway in Rats With Human Angiotensinogen Gene Transcripts. | 2019 |
1 |
| 9 |
30212210 | Trans and Cis Conformations of the Antihypertensive Drug Valsartan Respectively Lock the Inactive and Active-like States of Angiotensin II Type 1 Receptor: A Molecular Dynamics Study. | 2018 Oct 22 |
2 |
| 10 |
28338173 | Valsartan reduces AT1-AA-induced apoptosis through suppression oxidative stress mediated ER stress in endothelial progenitor cells. | 2017 Mar |
1 |
| 11 |
28387384 | Nebivolol/valsartan: Fixed-dose combination for treatment of hypertension. | 2017 Jan |
1 |
| 12 |
28400916 | Angiotensin receptor blocker drugs and inhibition of adrenal beta-arrestin-1-dependent aldosterone production: Implications for heart failure therapy. | 2017 Mar 26 |
1 |
| 13 |
28587583 | Angiotensin Receptor-Neprilysin Inhibition. | 2017 Jul |
2 |
| 14 |
26197716 | Angiotensin II promotes an osteoblast-like phenotype in porcine aortic valve myofibroblasts. | 2016 Apr |
1 |
| 15 |
26873036 | Combining angiotensin II receptor 1 antagonism and neprilysin inhibition for the treatment of heart failure. | 2016 Apr |
1 |
| 16 |
26995372 | Effect of Angiotensin II Type I Receptor Blockade with Valsartan on Carotid Artery Atherosclerosis: A Double Blind Randomized Clinical Trial Comparing Valsartan and Placebo (EFFERVESCENT). | 2016 Apr |
1 |
| 17 |
28133468 | Changing the treatment of heart failure with reduced ejection fraction: clinical use of sacubitril-valsartan combination. | 2016 Nov |
1 |
| 18 |
25591555 | Valsartan decreases platelet activity and arterial thrombotic events in elderly patients with hypertension. | 2015 Jan 20 |
1 |
| 19 |
25631300 | Suppression of adrenal βarrestin1-dependent aldosterone production by ARBs: head-to-head comparison. | 2015 Jan 29 |
1 |
| 20 |
25747524 | Nebivolol and valsartan as a fixed-dose combination for the treatment of hypertension. | 2015 Apr |
1 |
| 21 |
25853236 | A Single-Center, Open-Label, 3-Way Crossover Trial to Determine the Pharmacokinetic and Pharmacodynamic Interaction Between Nebivolol and Valsartan in Healthy Volunteers at Steady State. | 2015 Sep-Oct |
2 |
| 22 |
26466607 | The Role of Neprilysin Inhibitors in Cardiovascular Disease. | 2015 Dec |
1 |
| 23 |
24420549 | Intranasal angiotensin II in humans reduces blood pressure when angiotensin II type 1 receptors are blocked. | 2014 Apr |
1 |
| 24 |
25025993 | Agonistic autoantibodies against the angiotensin AT1 receptor increase in unstable angina patients after stent implantation. | 2014 Dec |
1 |
| 25 |
24070321 | Azilsartan medoxomil in the treatment of hypertension: the definitive angiotensin receptor blocker? | 2013 Nov |
1 |
| 26 |
24219285 | Angiotensin II downregulates ACE2-mediated enhancement of MMP-2 activity in human cardiofibroblasts. | 2013 Dec |
1 |
| 27 |
27122680 | Effect of 8-Week Combination Therapy with an Extended-Release α1-Blocker (Bunazosin or Doxazosin) in Inadequate Responders to an Angiotensin II Antagonist (Valsartan) in Patients with Stage 1 or 2 Essential Hypertension. | 2013 Jan |
1 |
| 28 |
22282241 | Valsartan inhibits angiotensin II-induced proliferation of vascular smooth muscle cells via regulating the expression of mitofusin 2. | 2012 Feb |
4 |
| 29 |
22392065 | Valsartan and telmisartan abrogate angiotensin II-induced downregulation of ABCA1 expression via AT1 receptor, rather than AT2 receptor or PPARγ activation. | 2012 Jun |
4 |
| 30 |
22967656 | Multi-class determination of personal care products and pharmaceuticals in environmental and wastewater samples by ultra-high performance liquid-chromatography-tandem mass spectrometry. | 2012 Sep 15 |
1 |
| 31 |
20615910 | Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy. | 2011 Jan |
1 |
| 32 |
20664555 | Angiotensin II receptor blockade with valsartan decreases plasma osteopontin levels in patients with essential hypertension. | 2011 May |
2 |
| 33 |
21324549 | Angiotensin II receptor blocker-induced angioedema in the oral floor and epiglottis. | 2011 Nov-Dec |
1 |
| 34 |
20329655 | Pharmacokinetic and bioequivalence study of two brands of valsartan tablets in healthy male volunteers. | 2010 |
2 |
| 35 |
20463030 | Nuclear-delimited angiotensin receptor-mediated signaling regulates cardiomyocyte gene expression. | 2010 Jul 16 |
1 |
| 36 |
20502651 | A short and efficient synthesis of valsartan via a Negishi reaction. | 2010 Mar 18 |
2 |
| 37 |
20504911 | Contribution of bradykinin B2 receptors to the inhibition by valsartan of systemic and renal effects of exogenous angiotensin II in salt-repleted humans. | 2010 Sep 1 |
1 |
| 38 |
21095266 | Rationale and design of a trial on the effect of angiotensin II receptor blockers on the function of the systemic right ventricle. | 2010 Nov |
1 |
| 39 |
19225232 | High ambient glucose augments angiotensin II-induced proinflammatory gene mRNA expression in human mesangial cells: effects of valsartan and simvastatin. | 2009 |
3 |
| 40 |
19417110 | Effects of angiotensin-converting enzyme inhibitor versus valsartan on cellular signaling events in heart transplant. | 2009 May |
1 |
| 41 |
19749478 | Angiotensin II receptor blocker, valsartan, increases myocardial blood volume and regresses hypertrophy in hypertensive patients. | 2009 Nov |
2 |
| 42 |
19911855 | Valsartan: more than a decade of experience. | 2009 |
2 |
| 43 |
17878892 | Angiotensin II stimulates and atrial natriuretic peptide inhibits human visceral adipocyte growth. | 2008 Feb |
2 |
| 44 |
18207159 | RGS5, RGS4, and RGS2 expression and aortic contractibility are dynamically co-regulated during aortic banding-induced hypertrophy. | 2008 Mar |
5 |
| 45 |
18331727 | Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R. | 2008 Apr 28 |
1 |
| 46 |
18633763 | Long-term effects of angiotensin II receptor blockade with valsartan on carotid arterial stiffness and hemodynamic alterations in patients with essential hypertension. | 2008 Jul |
2 |
| 47 |
18716376 | Angiotensin II increases expression of IP-10 and the renin-angiotensin system in endothelial cells. | 2008 Jun |
2 |
| 48 |
17146658 | Angiotensin II type 1 receptor 1166A/C polymorphism in association with blood pressure response to exogenous angiotensin II. | 2007 Jan |
1 |
| 49 |
17159079 | Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients. | 2007 Feb |
1 |
| 50 |
17261957 | Angiotensin II type 1 receptor blockade improves hyperglycemia-induced endothelial dysfunction and reduces proinflammatory cytokine release from leukocytes. | 2007 Jan |
1 |